Primer: Medy Tox Inc (086900 KS) - Aug 2026
Medy Tox stands at a critical juncture, with its future growth highly dependent on securing regulatory approvals for new products in key...
91 Views
KOSDAQ150 Index Rebalance Preview: Soaring AUM and Increased Flow/Impact
There could be 14 constituent changes for the KOSDAQ150 in June. AUM linked to the index has soared over the last couple of months. The forecast...
578 Views
Hugel Inc (145020 KS): Achieves Record High Revenue and Operating Profit in 4Q23
Hugel has received FDA approval for its botulinum toxin Letybo and becomes the only Korean company and one of the top 3 players globally that have...
869 Views
APAC Healthcare Weekly (June 28) – Insilico, Abbisko, Nippon Shinyaku, Otsuka, Yuhan Corp, Medytox
Few Chinese companies signed outlicensing deals. Nippon Shinyaku’s partner Regenxbio will resubmit gene therapy drug candidate to FDA. Otsuka...
144 Views
APAC Healthcare Weekly (June 14) – Wuxi AppTec, Remegen, CSPC Pharma, Takeda, SK Bioscience Alteogen
US DoD designated Wuxi AppTec as a “Chinese military company.” Takeda’s zasocitinib tops BMS’ Sotyktu in head-to-head trial. Alteogen secured...
132 Views